Minesh P. Mehta MD, FASTRO
Deputy Director and Chief of Radiation Oncology, Miami Cancer Institute; Professor and Chair, Department of Radiation Oncology, Florida International University, Miami, FloridaBiographical Sketch:
Dr. Minesh Mehta is Deputy Director of the Miami Cancer Institute and Chief of Radiation Oncology and Professor and Chair, Department of Radiation Oncology, Florida International University. He is also the NRG/Oncology Brain Tumor Committee Chair. Previously, he was Professor of Radiation Oncology at the University of Maryland School of Medicine and Medical Director of the Maryland Proton Treatment Center in Baltimore, where he still retains an adjunct faculty appointment.
Dr. Mehta received his medical degree from the University of Zambia in Lusaka, and, after completing an internship at Ndola Central Hospital in Ndola, Zambia, he completed residency training in radiation oncology at the University of Wisconsin, after which he was appointed to the faculty of the University of Wisconsin School of Medicine in the Department of Human Oncology. He was appointed to Chairman of the Department of Human Oncology in 1997, a position he held for 10 years. From 2010 to 2012, Dr. Mehta was Professor of Radiation Oncology at Northwestern University in Chicago, where he was also Co-Leader of the Robert H. Lurie Cancer Center Solid Tumor Investigational Program.
Dr. Mehta has published widely, including several hundred journal articles and book chapters in the fields of thoracic and central nervous system tumors. His research has also involved the areas of radiosensitizers, radioprotectors, and radiation oncology technology, specifically intensity-modulated, image-guided radiation therapy.
Dr. Mehta has had responsibilities in several leadership roles, including departmental chairmanship, residency program directorship, medical school course directorship, as well as leadership positions in several national organizations including the American Society of Clinical Oncology, the American Society for Radiation Oncology, and the FDA.
Positions:
Deputy Director and Chief of Radiation Oncology, Miami Cancer Institute, and Professor and Chair, Department of Radiation Oncology, Florida International University, Miami, Florida
Degree:
MB Ch B, University of Zambia
Clinical Interests:
Thoracic and central nervous system tumors
Research Interests:
Clinical trials; proton therapy; radiosensitizers, radioprotectors, and radiation oncology technology
Disclosures
Dr. Mehta discloses consulting relationships with Mevion, Karyopharm, Xoft and Sapience and individual stock holding in Chimerix.
Recent Contributions to PracticeUpdate:
- Current Drug Treatment Approaches for Brain Metastases—Part 4
- A Review of Immunotherapy and Targeted Therapy in Glioblastoma—Part 3
- CAR T-Cell Therapy in Secondary CNS Lymphoma
- Chemotherapy and Radiation Therapy for Gliomas—Part 2
- Ibrutinib Monotherapy for Relapsed or Refractory Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma
- Contemporary Assessment of Primary CNS Tumors and Role of Radiation Therapy—Part 1
- Intermittent High-Dose Lapatinib Alternating With Capecitabine Is Safe in Patients With HER2+ Breast Cancer With CNS Metastases
- Trastuzumab Emtansine + SRS Results in Significant Radionecrosis and Aquaporin-4 Dysregulation
- SRS With Concurrent Lapatinib Improved Breast Cancer Brain Metastasis Response
- Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases